Pediatric patients treated with proton therapy on the rise
the ONA take:
According to new research presented during the 54th annual Particle Therapy Co-Operative Group (PTCOG) Conference in San Diego, California, researchers from the Scripps Proton Therapy Center in San Diego have found that there has been a 36% increase in the number of pediatric patients who are being treated with proton therapy for cancerous and non-cancerous tumors.
For the study, researchers conducted a nationwide survey of all proton radiation therapy centers in the United States. Results showed that the number of pediatric patients treated with proton beam therapy has risen from 465 in 2010 to 722 patients in 2013.
Of pediatric patients treated with proton beam therapy in 2013, 56% were younger than 10 years of age and 26% were enrolled on multi-institutional registry studies.
The most common cancer tumor diagnoses among pediatric patients treated with proton therapy were ependymoma, medulloblastoma, and low-grade glioma.
There has been a 36% increase in the number of pediatric patients who are being treated with proton therapy for cancer.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses
- COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|